Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dasberg

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JAMA|April 6, 1984
Severe hypertension and lithium intoxicationJ Michaeli, D Ben-Ishay, R Kidron, et al.
Biological Psychiatry|June 1, 1979
Benzodiazepines in chronic schizophreniaP Ruskin, I Averbukh, R H Belmaker, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1988
Post-partum psychosis in adult GM2 gangliosidosis. A case reportP Lichtenberg, R Navon, E Wertman, et al.
Biological Psychiatry|February 1, 1980
Partial inhibition by lithium of the epinephrine-stimulated rise in plasma cyclic GMP in humansR H Belmaker, M Kon, R P Ebstein, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1989
Prescribing patterns of neuroactive drugs in 98 schizophrenic patientsU Heresco-Levy, D Greenberg, L Wittman, et al.
The Journal of Clinical Psychiatry|February 1, 1993
Trial of maintenance neuroleptic dose reduction in schizophrenic outpatients: two-year outcomeU Heresco-Levy, D Greenberg, B Lerer, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1995
Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapseU Heresco-Levy, D Greenberg, B Lerer, et al.
Clinical Pharmacology and Therapeutics|May 1, 1974
Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effectH H Dasberg, E van der Kleijn, J P Guelen, et al.
Psychopharmacology|June 21, 1979
The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactinR H Belmaker, R P Ebstein, H Dasberg, et al.
Psychopharmacology|January 1, 1981
Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patientsR Rimón, I Averbuch, P Rozick, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JAMA|April 6, 1984
Severe hypertension and lithium intoxicationJ Michaeli, D Ben-Ishay, R Kidron, et al.
Biological Psychiatry|June 1, 1979
Benzodiazepines in chronic schizophreniaP Ruskin, I Averbukh, R H Belmaker, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1988
Post-partum psychosis in adult GM2 gangliosidosis. A case reportP Lichtenberg, R Navon, E Wertman, et al.
Biological Psychiatry|February 1, 1980
Partial inhibition by lithium of the epinephrine-stimulated rise in plasma cyclic GMP in humansR H Belmaker, M Kon, R P Ebstein, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1989
Prescribing patterns of neuroactive drugs in 98 schizophrenic patientsU Heresco-Levy, D Greenberg, L Wittman, et al.
The Journal of Clinical Psychiatry|February 1, 1993
Trial of maintenance neuroleptic dose reduction in schizophrenic outpatients: two-year outcomeU Heresco-Levy, D Greenberg, B Lerer, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1995
Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapseU Heresco-Levy, D Greenberg, B Lerer, et al.
Clinical Pharmacology and Therapeutics|May 1, 1974
Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effectH H Dasberg, E van der Kleijn, J P Guelen, et al.
Psychopharmacology|June 21, 1979
The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactinR H Belmaker, R P Ebstein, H Dasberg, et al.
Psychopharmacology|January 1, 1981
Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patientsR Rimón, I Averbuch, P Rozick, et al.
Pageof 5